Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.

Journal of Cancer Research and Clinical Oncology
Pasquale ComellaSouthern Italy Cooperative Oncology Group

Abstract

Oxaliplatin combined with either fluorouracil/leucovorin (OXAFAFU) or capecitabine (OXXEL) has a demonstrated activity in metastatic colorectal cancer patients. We aimed at comparing these two regimens in terms of response rate (RR), safety, progression-free survival (PFS), and quality of life (QoL) of patients. A total of 322 patients with metastatic colorectal cancer were randomized to receive biweekly: oxaliplatin 100 mg/m(2) i.v. on day 1, capecitabine 1,000 mg/m(2) orally twice daily from day 1 to day 11 (OXXEL); or oxaliplatin 85 mg/m(2) i.v. on day 1; 6S-leucovorin 250 mg/m(2) i.v. and fluorouracil 850 mg/m(2) i.v. on day 2 (OXAFAFU). Eleven complete and 42 partial responses were registered with OXXEL (RR = 34%); six complete and 48 partial responses were obtained with OXAFAFU (RR = 33%) (P = 0.999). Severe adverse events were less frequent (32 vs. 43%) with OXXEL, which also reduced the occurrence of severe neutropenia (10 vs. 27%) and febrile neutropenia (6 vs. 13%), but produced more gastric side effects (8 vs. 3%) and diarrhea (13 vs. 8%). QoL did not differ across the two arms. Median PFS was 6.6 months in the OXXEL, and 6.5 months in the OXAFAFU arm (HR = 1.12, P = 0.354). Median overall survival was 16.0 and 17.1 ...Continue Reading

References

Jan 1, 1981·Cancer·A B MillerA Winkler
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G LiuE Warner
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaJ Pater
May 30, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Díaz-RubioM Homerin
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y BécouarnP Rougier
Dec 3, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E RaymondE Cvitkovic
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S GiacchettiF Lévi
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Markus M BornerArnaud D Roth
Sep 5, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ZeuliF Cognetti
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jim CassidyEduardo Díaz-Rubio
Dec 14, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C TwelvesL Samuel
Oct 3, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P PfeifferA Jakobsen
Nov 14, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andrea Angelo MartoniEdera Piana
Jun 6, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo Díaz-RubioUNKNOWN Spanish Cooperative Group for the Treatment of Digestive Tumors Trial
Jun 6, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rainer PorschenUNKNOWN AIO Colorectal Study Group
Aug 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J Mayer
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard S HochsterEric Hedrick

❮ Previous
Next ❯

Citations

Jan 22, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Timothy M Pawlik, David Cosgrove
Nov 8, 2012·Journal of Gastrointestinal Cancer·Sacha Satram-HoangEdward McKenna
Aug 1, 2007·Clinics in Colon and Rectal Surgery·Smitha S KrishnamurthiTimothy J Kinsella
Feb 18, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·Y CaoF Gao
Jun 3, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G ZhaoB Ma
May 14, 2009·Therapeutics and Clinical Risk Management·Pasquale ComellaLuca Franco
May 31, 2014·World Journal of Gastroenterology : WJG·Carlos AguadoEduardo Díaz-Rubio
Sep 28, 2013·Journal of Geriatric Oncology·Carlos GrandeUNKNOWN Grupo Gallego de Investigaciones Oncológicas (GGIO)
Oct 12, 2010·Journal of Cancer Research and Clinical Oncology·Wei LingHongxia Wang
Oct 21, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Panattharin LerdkiattikornYot Teerawattananon
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Michel DucreuxUNKNOWN GI Group of the French Anti-Cancer Centers
Oct 9, 2016·Cancer Treatment Reviews·Krzysztof AdamowiczJacek Jassem
Nov 9, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kaitlyn K H GoeyMiriam Koopman
Jul 18, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Aaron ShaSharlene Gill
Jul 29, 2017·The Cochrane Database of Systematic Reviews·Fiona ChionhNiall Tebbutt
Mar 7, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Vincent Chee Ee PhuaWan Zamaniah Wan Ishak
Dec 8, 2020·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Toshikazu MoriwakiIchinosuke Hyodo
Dec 22, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C S E W SchuurhuizenH M W Verheul

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

© 2022 Meta ULC. All rights reserved